Here's Why Boston Scientific (BSX) is a Strong Growth Stock

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence [1] Zacks Style Scores - Zacks Style Scores are indicators that assist investors in selecting stocks likely to outperform the market within 30 days, rated from A to F based on value, growth, and momentum [2] - The Value Score identifies attractive and discounted stocks using ratios like P/E, PEG, and Price/Sales [2] - The Growth Score focuses on a company's financial health and future outlook, analyzing projected and historical earnings, sales, and cash flow [3] - The Momentum Score helps investors capitalize on price trends by evaluating short-term price changes and earnings estimate shifts [3] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for stock selection based on value, growth, and momentum [4] Zacks Rank and Style Scores Integration - The Zacks Rank utilizes earnings estimate revisions to guide investors in building successful portfolios, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [5] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal success [6] - Stocks with lower ranks, even with high Style Scores, may still face downward earnings forecasts, increasing the risk of price declines [6] Company Spotlight: Boston Scientific - Boston Scientific Corporation, founded in 1979 and headquartered in Natick, MA, specializes in manufacturing medical devices for various interventional specialties globally [7] - The company holds a Zacks Rank of 2 (Buy) and a VGM Score of B, making it a strong candidate for growth investors [7] - Boston Scientific is projected to achieve year-over-year earnings growth of 17.1% for the current fiscal year, with 12 analysts raising earnings estimates for fiscal 2024 [7] - The Zacks Consensus Estimate for Boston Scientific has increased by $0.08 to $2.40 per share, with an average earnings surprise of 7.2% [7]